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Yanming Zhou1*†, Yaqing Xiao2†, Lupeng Wu1, Bin Li1 and Hua Li2*Abstract
Background: The safety and efficacy of laparoscopic liver resection (LLR) for colorectal liver metastasis (CLM)
remain to be established. A meta-analysis was undertaken to compare LLR and open liver resection (OLR) for CLM
with respect to surgical and oncologic outcomes.
Methods: An electronic search was performed to retrieve all relevant articles published in the English language by
the end of March 2013. Data were analyzed using Review Manager version 5.0.
Results: A total of 8 nonrandomized controlled studies with 695 subjects were analyzsed. Intra-operative blood loss, the
proportion of patients requiring blood transfusion, morbidity and the length of hospital stay were all significantly reduced
after LLR. Postoperative recurrence, 5-year overall and disease-free survivals were comparable between two groups.
Conclusions: LLR for CLM is safe and efficacious. It improves surgical outcomes and uncompromises oncologic
outcomes as compared with OLR.
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Colorectal cancer (CRC) is among the most frequently
encountered malignant neoplasms in the world. Ap-
proximately 50% CRC patients developed liver metasta-
sis during disease evolution, which is a major cause of
cancer death [1]. Conventional open liver resection (OLR)
is an effective treatment for colorectal liver metastasis
(CLM), offering a 5-year survival of 16-74% and a 10-year
survival of 9-69% [2].
Lparoscopic liver resection (LLR) was first reported as
a minimally invasive procedure two decades ago [3], but
many surgeons are reluctant to accept it as an alterna-
tive to an open approach due to the potential risks
of intraoperative complications and oncologic adequacy.
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reproduction in any medium, provided the orin the laparoscopic field in recent years, increased numbers
of reports on LLR have been published [4]. A number
of case-series reports and comparative trials have
demonstrated the potential benefits, safety and feasibility
of LLR for CLM [5-16]. However, no related evidence
has been reviewed systematically. In accordance with
recommendations of the Preferred Reporting Items
for Systematic Reviews and Meta-Analyses (PRISMA)
Statement [17], we made a meta-analysis to provide a
better quality of evidence in the literature to support
the recommendation of LLR as an alternative option
for CLM treatment.Methods
Study selection and data extraction
A MEDLINE, EMBASE, OVID, and Cochrane database
were searched to identify all clinical trials published as
full papers in the English language that compared LLR
and OLR for CLM between July 1992 and March 2013.
The following Mesh search headings were used: “laparo-
scopic liver resection”, “colorectal cancer”, and “colorec-
tal liver metastases”. The bibliographies of relevanttd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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trials.
The following parameters were extracted from each
study and tabulated by two investigators (BL and LPW)
independently: name of first authors, year of publication,
study design, number of patients in each arm, patient
baseline characteristics, and outcomes of interest. All
relevant texts, tables and figures were reviewed for data
extraction. If the study provided medians and interquar-
tile ranges instead of means and SDs, the means and
SDs were imputed as described by Hozo et al. [18].
Discrepancies between the reviewers were resolved by
discussion and consensus.
Outcomes of interests
Surgical outcomes: operative parameters (duration of
operation, intra-operative blood loss, and need for blood
transfusion), postperative adverse events (morbidity and
mortality rates), and postoperative recovery (hospital
stay, time to bowel movement, time to oral intake, and
requirement for analgesia).
Oncologic outcomes: resection margin, recurrence,
5-year overall survival (OS) and disease-free survival (DFS).
Criteria for inclusion and exclusion
To be included in the analysis, a study had to compare
LLR and OLR for CLM. If dual (or multiple) studies
were reported by the same institution, only the most re-
cent was used. Unpublished studies, abstracts, letters,
proceedings from scientific meetings, editorials and ex-
pert opinions, reviews without original data, case reports
and studies lacking control groups were excluded. Trials
that involved heterogeneous groups of patients with a
variety of hepatic disesase were also excluded.Figure 1 Selection flow diagram.Qualitative analysis
The methodological quality of the included trials was
assessed according to the Newcastle-Ottawa Scale (NOS),
which scores patient selection, comparability of the two
study groups, and assessment of outcomes [19]. Studies
achieving more than 6 points (maximum 11) were defined
as higher quality.
Statistical methods
All data were analyzed using the Review Manager ver-
sion 5.0 (The Cochrane Collaboration, Software Update,
Oxford) and P < 0.05 was considered statistically signifi-
cant. Analyses were performed using odds ratios (OR)
with a 95% confidence interval (95% CI) for dichotom-
ous variables and weighted mean differences (WMD)
with a 95% CI for continuous variables. Heterogeneity
was evaluated by χ2 and I2. Data that were not signifi-
cantly heterogeneous (P > 0.1) were calculated using a
fixed effects model, and heterogeneous data (P < 0.1)
were calculated using a random-effects model. Publica-
tion bias was assessed visually using a funnel plot for
standard error by effect size (log OR).
Results
Eligible studies
Figure 1 demonstrates a flow chart of the selection
process that yielded a total of 8 non-randomized com-
parative studies published between 2002 and 2013 that
matched the criteria of inclusion and exclusion and were
included in the current meta-analysis [9-16]. The char-
acteristics of these 8 studies are summarized in Table 1.
The 8 studies included a total of 695 patients: 268 in
LLR group and 427 in OLR group. Two studies were
conducted in the United States [13,15], one in Norway [9],
Table 1 Baseline characteristics of the studies included in the meta-analysis












Mala et al. [9] 2002 Norway LLR 13 4/9 68 (55–73) 2 2.6 (1–6) 2 (1–7) 0 *****
OLR 14 4/10 59 (24–74) 2 3 (1.5-9) 1 (1–4)
Castaing et al. [10] 2009 France LLR 60 37/23 62 ± 11 26 3.3 ± 1.1 2.2 ± 2.3 6 (10) *******
OLR 60 37/23 62 ± 11 24 4.4 ± 3.8 2.2 ± 1.98
Abu et al. [11] 2010 United Kingdom LLR 50 28/22 66 (42–85) 19 3.15 (0.3–9) 1 (1–3) 6 (12) ******
OLR 85 55/30 67 (47–86) 46 – –
Cheung et al. [12] 2012 Hong Kong LLR 20 13/7 57.5 (42–74) 1 1.5 (0.5–4.5) 1 (1–2) 0 *******
OLR 40 29/11 64 (29–83) 2 2.2 (0.5–7) 1 (1–2)
Cannon et al. [13] 2012 United States LLR 35 – 62 ±10 19 4 ±3 1 ± 1 – *******
OLR 138 – 62 ±11 71 5 ± 3 1 ± 1
Topal et al. [14] 2012 Belgium LLR 20 10/10 57.6 20 4 (0.4–7) 2 (1–6) – ******
OLR 20 8/12 66.0 20 3.2 (1–12.5) 2 (1–14)
Guerron et al. [15] 2013 United States LLR 40 21/19 66.2 ± 1.9 5 3.3 ± 0.3 1.3 ± 0.1 2 (5) *******
OLR 40 15/25 62.2 ± 1.8 9 3.2 ± 0.3 1.7 ± 0.1
Qiu et al. [16] 2013 China LLR 30 14/16 52.5 ± 11.5 2 2.5 ± 2.0 ≥2 (n=10) 2 (6.6) ********
OLR 30 15/15 – 5 2.8 ± 1.5 ≥2 (n=9)

















Table 2 Results of a meta-analysis comparing laparoscopic versus open liver resection for colorectal liver metastasis
Outcome of interest No. of studies No. of participants OR/WMD 95% CI P-value I2 (%)
Operative outcomes
Operative time 7 9–12,14–16 LLR = 235, OLR= 289 1.91 −15.92, 19.75 0.83 49
Blood loss 7 9,11–16 LLR = 210, OLR= 367 −173.08 −297.52, -48.64 0.006 83
Blood transfusions requirement 4 10,12,13,15 LLR = 155, OLR= 278 0.35 0.20, 0.64 < 0.001 0
Overall morbidity 8 9–16 LLR = 270, OLR= 427 0.56 0.39, 0.82 0.003 0
Mortality 8 9–16 LLR = 268, OLR= 427 0.69 0.13, 3.75 0.67 0
Hospital stay 6 9,10,12,14–16 LLR = 185, OLR= 204 −3.54 −5.12, -1.96 < 0.001 75
Oncologic outcomes
Negative surgical margin 6 9–11,13,14,16 LLR = 208, OLR= 347 2.97 1.53, 5.78 0.001 0
Recurrence 310,11,15 LLR = 150, OLR = 185 0.68 0.41, 1.14 0.14 0
5-year overall survival 4 10,12–14 LLR = 135, OLR= 258 1.33 0.86, 2.07 0.20 41
5-year disease-free survival 4 10,12–14 LLR = 135, OLR= 258 1.48 0.89, 2.44 0.13 45
OR odds ratio, WMD weighted mean difference, CI confidence interval.
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in Hong Kong [12], one in Belgium [14], and one in
Mainland China [16]. The sample size of the included
studies ranged from 27 to 173 patients. The patient
baseline characteristics including sex, age, and the number
and size of metastases were well matched between the
two groups in all the 8 studies. Only one study conducted
by Cannon et al. [13] had differences in type of resections.
In their series, left lateral segmentectomy was significantly
more common in the laparoscopic group, while wedge
resection/bisegmentectomy was significantly more common
in the open group.
The methods of patient selections and indications for
LLR were reported in four studies [10,11,13,16]. In gen-
eral, patients with centrally located lesions such as those
near the hilum or in proximity to the hepatic veins were
considered unsuitable for the laparoscopic approach.
Six of the 8 studies reported on the conversion rate in
LLR group, which ranged from 0 to 12% [9-12,15,16].
The overall conversion rate was 8.2% (16/193). The rea-
sons for conversion were bleeding (n=5), massive adhe-
sions (n=4), inadequate hemostasis (n=2), peritonealFigure 2 Forest plot displaying the results of the meta-analysis on potumor implants (n=1), control of the right or middle
hepatic vein (n=2), multiple hepatic metastases (n=1),
and diagnostic uncertainty (n =1).
Meta-analysis of surgical outcomes
Table 2 presents a summary of outcomes. Regarding the
operative parameters, differences in the duration of oper-
ation were not statistically significant (7 trials reported this
datum, WMD: 1.91, 95% CI: -15.92 to 19.75; P =0.83), while
intra-operative blood loss was significantly lower in LLR
group (7 trials reported this datum, WMD: -173.08, 95%
CI: -297.52 to −48.64; P = 0.006). Consequently, the pro-
portion of patients requiring blood transfusion was lower in
LLR group (4 trials reported this datum, OR: 0.35,
95% CI: 0.20 to 0.64; P <0.001). Significant heterogeneity
of difference in operation duration and blood loss was
observed between the studies (P < 0.1).
Regarding the postoperative adverse events, patients in
the laparoscopic group had lower morbidity than those
in the open resection group (all 8 trials reported this
datum, 21.1% vs. 33.7%; P = 0.003) (Figure 2). Overall,
postoperative mortality occurred only in one patient instoperative morbidity.
Figure 3 Forest plot displaying the results of the meta-analysis on hospital stay.
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reported this datum, 0.3% vs. 0.9%; P = 0.67). There was
no significant heterogeneity between studies in reporting
these two outcomes.
Regarding postoperative recovery, Mala et al. [9] re-
ported the median duration of postoperative usage of
analgesia, which was 1 (0–7) days in laparoscopic resec-
tion group compared with 5 (2–11) days in the open
group (P < 0.001). Qiu et al. [16] reported that the total
dosage and frequency of analgesic administration in LLR
group were significantly lower than those in OLR group
(30.2 ± 20.8 vs. 70.3 ± 38.5mg, P < 0.001; 2.0 ± 0.5 vs.
4.0 ± 0.8, P < 0.001). They also found that the time to the
return of bowel function, passage of feces and soft diet tol-
erance occurred significantly earlier in LLR group (1.0 ± 0.9
vs. 2.4 ± 1.8 days, P < 0.001; 2.2 ± 0.7 vs. 4.0 ± 1.5 days,
P < 0.001; 1.8 ± 1.2 vs. 3.2 ± 1.0 days, P < 0.001). All studies
reported on the length of hospital stay, and two studies
were excluded due to present data as median without range
[11,13]. The pooled analysis of the 6 studies showed that
hospital stay was shorter in the laparoscopic group
(WMD: -3.54, 95% CI: -5.12 to −1.96; P < 0.001) with
significant heterogeneity (I2 = 75%, P =0.001) (Figure 3).Meta-analysis of oncologic outcomes
Six of the 8 studies reported the pathological resection
margin status [9-11,13,14,16]. The pooled analysis
showed that patients undergoing laparoscopic resection
had a higher incidence of negative margin resection than
patients in the open group (93.7 % vs. 84.4%; P= 0.001)Figure 4 Forest plot displaying the results of the meta-analysis on ne(Figure 4). Regarding recurrence, pooled data on three
studies showed no difference between two groups (33.3%
vs. 37.3%; P= 0.14). No recurrence at laparoscopic port
sites was reported in all 8 included studies.
Regarding survival, four studies reported 5-year OS
and DFS [10,12-14], both of which were comparable
between two groups (51.8% vs. 39.9%; P = 0.20;
28.8% vs. 20.5%; P = 0.13, respectively). In one study,
2-year OS was 89 % for LLR and 81% for open resection
(P = 0.283). Median DFS was also similar in the two groups
(23 vs. 23 months; P = 0.904) [15].
Publication bias
The funnel plot of standard of error by effect estimate of
morbidity showed none of the studies lay outside the
limits of the 95% CI, indicating no evidence of publication
bias (Figure 5).
Discussion
Compared with open surgery, the laparoscopic approach
confers patients with benefits such as diminished post-
operative pain, less operative trauma, faster recovery,
and shorter hospital stay. During the two decades, min-
imally invasive surgery has been applied to various ab-
dominal surgical procedures. Initial evidence in support
of LLR for CLM was mostly from case series and thus
limited by small sample size and the lack of a compara-
tor [5-8]. In 2007, Simillis et al. [20] performed the first
meta-analysis by comparing LLR with OLR for benign
and malignant tumors in 8 studies published between
1998 and 2005. Subsequently, two updated meta-gative margin resection.
Figure 5 Funnel plot analysis of publication bias.
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ever, only one study with CLM only was included in the
three meta-analyses [9]. In the present meta-analysis, we
included 8 studies covering 695 patients, which may
represent the largest body of information so far available
for the comparison of LLR and OLR for CLM in the
literature.
With respect to operative parameters, blood loss and
transfusion requirements for LLR were significantly
lower than those of OLR. This difference can be attrib-
uted to the magnification of images and more meticu-
lous dissection, pneumoperitoneum, and less blood loss
from the abdominal wall provided by the laparoscopic
approach [23]. As both the amount of blood loss and the
need for transfusion have been associated with increased
postperative morbidity [24], it is reasonable to note that pa-
tients in the laparoscopic group had lower morbidity.
Concerning postoperative recovery, patients undergo-
ing laparoscopic resection required smaller doses and
less frequency of analgesic administration, and experi-
enced more rapid recovery of bowel function [9,16]. As
expected, LLR significantly reduced the length of hos-
pital stay by 3.5 days.
LLR is associated with reduced postoperative morbidity
and a shorter length of hospital stay. Hence, LLR may very
likely outweigh the higher costs of the laparoscopic tech-
nique. Although we did not compare the costs between the
two procedures due to inadequate data, a recent deviation-
based cost modeling study compared the economic impact
of laparoscopic versus open left lateral sectionectomy and
found that the cost of each patient undergoing LLR was US
$ 2,939 less than that of a patient undergoing a similar open
operation on average [25].
The most important question regarding the use of
LLR for the treatment of CLM is its oncologic efficiency.Port-site tumor metastasis in early repots of other types
of gastrointestinal malignancy has increased the doubt
about the oncologic safety of the laparoscopic approach
[26]. However, port-site tumor metastasis or peritoneal
carcinomatosis was not identified in any of the 8 in-
cluded studies. Meticulous intraoperative manipulation,
adoption of no-touch technique, and use of plastic bags
to retrieve the specimen would prevent the port-site
tumor metastasis. Currently, complete macroscopic re-
moval of all lesions with negative resection margins is
established as the gold standard of care of CLM. In our
analysis, negative margins were achieved in 93.6% of the
patients, and such an excellent result may be attributed
to the routine use of intraoperative ultrasonography.
Finally, our study showed that the 5-year OS, DFS and
postoperative recurrence did not differ significantly be-
tween the two groups. Therefore, the laparoscopic ap-
proach has no negative effect on oncologic outcomes of
surgery for CLM.
After hepatic resection, approximately 60% of the pa-
tients with CLM would develop recurrent disease, often
isolated to the liver. Repeat hepatectomy is an effective
treatment that offers long-term survival for these pa-
tients. However, peri-hepatic adhesions caused by the
initial operation may prolong the operative duration and
increase blood loss [27]. Given its advantage of minimal
adhesion formation, laparoscopic techniques facilitate
repeat hepatectomy, and the procedure is better toler-
ated by patients [23].
Approximately 25% of CRC patients have synchronous
CLM at the time of diagnosis. Laparoscopy could facili-
tate the operative approach of a simultaneous procedure.
Several case reports and small series have demonstrated
the safety and benefit as well as good oncologic outcome
of this strategy [28-31].
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with caution for several reasons. First, it should be noted
that patients who underwent LLR were a highly selected
population. In general, lesions located in the antero-
lateral segments of the liver are good candidates for
LLR. In contrast, lesions located adjacent to major ves-
sels or requiring vascular or biliary reconstruction are
inappropriate for LLR. Second, all the trials available are
observational in nature, which inevitably introduces
selection bias and may produce confounding results.
However, it would be difficult to recruit patients for
conducting a prospective randomized controlled trial to
compare a less invasive procedure versus an invasive
procedure. Third, the included number of patients was
relatively small, which could reduce the reliability and
validity of results. However, encouraging data of LLR for
CLM also have been reported in recently published two
large cohort studies involving more than 100 patients
[23,32]. Kazaryan and colleagues, in a single center study
of 122 LLRs for CLM, reported that the morbidity and
mortality rates were 14.3% and 0%, respectively, and the
5-year actuarial overall and disease-free survivals were
51% and 42%, respectively [23]. Nguyen and colleagues,
in a retrospective study of 109 LLRs for CLM in 5 med-
ical centers, reported that the morbidity and mortality
rates were 12% and 0%, respectively, and the 5-year
overall and disease-free survivals were 50% and 43%, re-
spectively [32]. Finally, LLR is suggested as a more tech-
nically demanding procedure and is associated with a
learning curve, especially in cases that need more major
resections. A study involving 74 patients who underwent
LLR indicates that increased experience confers better
results in terms of the conversion rate, operative time,
blood loss and morbidity. The studies included in our
analysis did have surgeons of varying experience with LLR
[33], but unfortunately none of these studies reported on
their initial experience of this technique. Therefore, we were
unable to perform a subgroup analysis regarding the effect
of learning curve on surgical outcomes.
Conclusions
Our meta-analysis has shown that LLR for CLM is asso-
ciated with improved surgical outcomes and uncom-
promising oncologic outcomes compared to OLR. These
findings provide evidence to support its use as a safe
and efficacious alternative to open resection for CLM.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
YZ participated in the design and coordination of the study, carried out the
critical appraisal of studies and wrote the manuscript. LW and YX developed the
literature search, carried out the extraction of data, assisted in the critical appraisal
of included studies and assisted in writing up. HL and BL carried out the
statistical analysis of studies. All authors read and approved the final manuscript.Acknowledgements
We thank Doctor Yanfang Zhao (Department of Health Statistics, Second
Military Medical University, Shanghai, China) for her critical revision of the
meta-analysis section.
Author details
1Department of Hepatobiliary & Pancreatovascular Surgery, Oncologic Center
of Xiamen, First affiliated Hospital of Xiamen University, Xiamen, China.
2Department of Digestive Diseases, First affiliated Hospital of Xiamen
University, Xiamen, China.
Received: 4 June 2013 Accepted: 27 September 2013
Published: 1 October 2013
References
1. Mohammad WM, Balaa FK: Surgical management of colorectal liver
metastases. Clin Colon Rectal Surg 2009, 22:225–232.
2. Kanas GP, Taylor A, Primrose JN, et al: Survival after liver resection in
metastatic colorectal cancer: review and meta-analysis of prognostic
factors. Clin Epidemiol 2012, 4:283–301.
3. Reich H, McGlynn F, DeCaprio J, et al: Laparoscopic excision of benign
liver lesions. Obstet Gynecol 1991, 78:956–958.
4. Nguyen KT, Gamblin TC, Geller DA: World review of laparoscopic liver
resection-2,804 patients. Ann Surg 2009, 250:831–841.
5. Gigot JF, Glineur D, Santiago Azagra J, et al: Laparoscopic liver resection
for malignant liver tumors: preliminary results of a multicenter European
study. Ann Surg 2002, 236:90–97.
6. O’Rourke N, Shaw I, Nathanson L, et al: Laparoscopic resection of hepatic
colorectal metastases. HPB (Oxford) 2004, 6:230–235.
7. Vibert E, Perniceni T, Levard H, et al: Laparoscopic liver resection. Br J Surg
2006, 93:67–72.
8. Tang CN, Tsui KK, Ha JP, et al: A single-centre experience of 40
laparoscopic liver resections. Hong Kong Med J 2006, 12:419–425.
9. Mala T, Edwin B, Gladhaug I, et al: A comparative study of the short-term
outcome following open and laparoscopic liver resection of colorectal
metastases. Surg Endosc 2002, 16:1059–1063.
10. Castaing D, Vibert E, Ricca L, et al: Oncologic results of laparoscopic versus
open hepatectomy for colorectal liver metastases in two specialized
centers. Ann Surg 2009, 250:849–855.
11. Abu Hilal M, Underwood T, Zuccaro M, et al: Short- and medium-term
results of totally laparoscopic resection for colorectal liver metastases.
Br J Surg 2010, 97:927–933.
12. Cannon RM, Scoggins CR, Callender GG, et al: Laparoscopic versus open
resection of hepatic colorectal metastases. Surgery 2012, 152:567–573.
13. Cheung TT, Poon RT, Yuen WK, et al: Outcome of laparoscopic versus
open hepatectomy for colorectal liver metastases. ANZ J Surg 2012.
Epub ahead of print.
14. Topal H, Tiek J, Aerts R, et al: Outcome of laparoscopic major liver
resection for colorectal metastases. Surg Endosc 2012, 26:2451–2455.
15. Guerron AD, Aliyev S, Agcaoglu O, et al: Laparoscopic versus open
resection of colorectal liver metastasis. Surg Endosc 2013, 27:1138–1143.
16. Qiu J, Chen S, Pankaj P, et al: Laparoscopic hepatectomy for hepatic
colorectal metastases - a retrospective comparative cohort analysis and
literature review. PLoS One 2013, 8:e60153.
17. Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group: Preferred
reporting items for systematic reviews and meta-analyses: the PRISMA
statement. PLoS Med 2009, 6:e1000097.
18. Hozo SP, Djulbegovic B, Hozo I: Estimating the mean and variance from the
median, range, and the size of a sample. BMC Med Res Methodo 2005, 5:13.
19. Athanasiou T, Al-Ruzzeh S, Kumar P, et al: Off-pump myocardial
revascularization is associated with less incidence of stroke in elderly
patients. Ann Thorac Surg 2004, 77:745–753.
20. Simillis C, Constantinides VA, Tekkis PP, et al: Laparoscopic versus open
hepatic resections for benign and malignant neoplasms–a meta-analysis.
Surgery 2007, 141:203–211.
21. Croome KP, Yamashita MH: Laparoscopic vs open hepatic resection for
benign and malignant tumors: An updated meta-analysis. Arch Surg 2010,
145:1109–1118.
22. Mirnezami R, Mirnezami AH, Chandrakumaran K, et al: Short- and long-term
outcomes after laparoscopic and open hepatic resection: systematic
review and meta-analysis. HPB (Oxford) 2011, 13:295–308.
Zhou et al. BMC Surgery 2013, 13:44 Page 8 of 8
http://www.biomedcentral.com/1471-2482/13/4423. Kazaryan AM, Marangos IP, Røsok BI, et al: Laparoscopic resection of
colorectal liver metastases: surgical and long-term oncologic outcome.
Ann Surg 2010, 252:1005–1012.
24. Wu WC, Smith TS, Henderson WG, et al: Operative blood loss, blood
transfusion, and 30-day mortality in older patients after major
noncardiac surgery. Ann Surg 2010, 252:11–17.
25. Vanounou T, Steel JL, Nguyen KT, et al: Comparing the clinical and
economic impact of laparoscopic versus open liver resection. Ann Surg
Oncol 2010, 17:998–1009.
26. Reza MM, Blasco JA, Andradas E, et al: Systematic review of laparoscopic
versus open surgery for colorectal cancer. Br J Surg 2006, 93:921–928.
27. Antoniou A, Lovegrove RE, Tilney HS, et al: Meta-analysis of clinical
outcome after first and second liver resection for colorectal metastases.
Surgery 2007, 141:9–18.
28. Leung KL, Lee JF, Yiu RY, et al: Simultaneous laparoscopic resection of
rectal cancer and liver metastasis. J Laparoendosc Adv Surg Tech A 2006,
16:486–488.
29. Geiger TM, Tebb ZD, Sato E, et al: Laparoscopic resection of colon cancer
and synchronous liver metastasis. J Laparoendosc Adv Surg Tech A 2006,
16:5153.
30. Lupinacci RM, Machado MA, Lupinacci RA, et al: Simultaneous left
colectomy and standard hepatectomy reformed by laparoscopy. Rev Col
Bras Cir 2011, 38:139–141.
31. Polignano FM, Quyn AJ, Sanjay P, et al: Totally laparoscopic strategies for
the management of colorectal cancer with synchronous liver metastasis.
Surg Endosc 2012, 26:2571–2578.
32. Nguyen KT, Laurent A, Dagher I, et al: Minimally invasive liver resection for
metastatic colorectal cancer: a multi-institutional, international report of
safety, feasibility, and early outcomes. Ann Surg 2009, 250:842–848.
33. Vigano L, Laurent A, Tayar C, et al: The learning curve in laparoscopic liver
resection: improved feasibility and reproducibility. Ann Surg 2009,
250:772–782.
doi:10.1186/1471-2482-13-44
Cite this article as: Zhou et al.: Laparoscopic liver resection as a safe
and efficacious alternative to open resection for colorectal liver
metastasis: a meta-analysis. BMC Surgery 2013 13:44.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
